146 related articles for article (PubMed ID: 11790612)
1. Targeted taxane therapy for cancer.
Whelan J
Drug Discov Today; 2002 Jan; 7(2):90-2. PubMed ID: 11790612
[No Abstract] [Full Text] [Related]
2. Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice.
Sharma A; Straubinger RM; Ojima I; Bernacki RJ
J Pharm Sci; 1995 Dec; 84(12):1400-4. PubMed ID: 8748320
[TBL] [Abstract][Full Text] [Related]
3. Improved chemical strategies for the targeted therapy of cancer.
Maison W; Frangioni JV
Angew Chem Int Ed Engl; 2003 Oct; 42(39):4726-8. PubMed ID: 14562338
[No Abstract] [Full Text] [Related]
4. Preclinical evaluation of new taxoids.
Bissery MC
Curr Pharm Des; 2001 Sep; 7(13):1251-7. PubMed ID: 11472265
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Taxane-Pretreated Metastatic Gastric Cancer with Excellent Response to Nab-Paclitaxel].
Kawabata R; Kimura Y; Kawase T; Yoshikawa M; Kameda C; Matsumura T; Koga C; Murakami M; Hirota M; Noura S; Ikenaga M; Shimizu J; Hasegawa J
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2088-90. PubMed ID: 26805273
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
7. Optimizing taxane use in MBC in the emerging era of targeted chemotherapy.
von Minckwitz G; Martin M; Wilson G; Alba E; Schmidt M; Biganzoli L; Awada A
Crit Rev Oncol Hematol; 2013 Mar; 85(3):315-31. PubMed ID: 23116625
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC.
Ardizzoni A; Tiseo M; Boni L; Di Maio M; Buffoni L; Belvedere O; Grossi F; D'Alessandro V; de Marinis F; Barbera S; Caroti C; Favaretto A; Cortinovis D; Morrica B; Tixi L; Ceschia T; Parisi S; Ricardi U; Grimaldi A; Loreggian L; Navarria P; Huber RM; Belani C; Brunsvig PF; Scagliotti GV; Scolaro T
Lung Cancer; 2016 Oct; 100():30-37. PubMed ID: 27597278
[TBL] [Abstract][Full Text] [Related]
9. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].
Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840
[No Abstract] [Full Text] [Related]
10. Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane.
Singer JW
J Control Release; 2005 Dec; 109(1-3):120-6. PubMed ID: 16297482
[TBL] [Abstract][Full Text] [Related]
11. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
Sparano JA
Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
[TBL] [Abstract][Full Text] [Related]
12. Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane).
Cella D; Peterman A; Hudgens S; Webster K; Socinski MA
Cancer; 2003 Aug; 98(4):822-31. PubMed ID: 12910528
[TBL] [Abstract][Full Text] [Related]
13. New microtubular agents in pediatric oncology.
Seibel NL; Reaman GH
Invest New Drugs; 1996; 14(1):49-54. PubMed ID: 8880393
[TBL] [Abstract][Full Text] [Related]
14. Taxane-based therapy for breast cancer: combination or sequential therapy?
Sparano JA; Rajdev L
Cancer Invest; 2000; 18(5):498-500. PubMed ID: 10834036
[No Abstract] [Full Text] [Related]
15. Role of taxanes in adjuvant therapy.
Münster PN; Hudis CA
Cancer Invest; 2000; 18(1):32-8. PubMed ID: 10701365
[No Abstract] [Full Text] [Related]
16. Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
Blum JL; Dees EC; Vukelja SJ; Amare M; Gill DP; McMahon RT; Ilegbodu D; Asmar L; O'Shaughnessy JA
Clin Breast Cancer; 2007 Feb; 7(6):465-70. PubMed ID: 17386123
[TBL] [Abstract][Full Text] [Related]
17. Polymer-conjugated paclitaxel as a radiosensitizing agent--a big step forward for combined modality therapy?
Tishler RB
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):563-4. PubMed ID: 12573741
[No Abstract] [Full Text] [Related]
18. New form of paclitaxel shows promise.
Garfield D
Lancet Oncol; 2001 Apr; 2(4):192. PubMed ID: 11905759
[No Abstract] [Full Text] [Related]
19. Role of taxanes in the combined modality treatment of patients with locally advanced non-small cell lung cancer.
Choy H; Pyo H; Kim JS; MacRae R
Expert Opin Pharmacother; 2001 Jun; 2(6):963-74. PubMed ID: 11585012
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel: today's results and tomorrow's promises.
Hortobagyi GN
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):11-4. PubMed ID: 9364535
[No Abstract] [Full Text] [Related]
[Next] [New Search]